Positives

• Long COVID patients with mast-cell-overlap symptoms (fatigue, brain fog, GI issues, palpitations) commonly report meaningful symptom relief on desloratadine, often as part of a non-sedating H1 blocker backbone titrated up to four times the labeled dose PMC.
• Compared with first-generation antihistamines, patients report desloratadine produces less drowsiness and brain fog while still providing the long-acting H1 blockade most MCAS-overlap Long COVID patients need Asia Pacific Allergy.

Negatives

• One WebMD reviewer with chronic spontaneous urticaria reported that Clarinex was not effective at all for controlling their hives, mirroring the same gap many MCAS patients describe with single-agent H1 blockade WebMD.
• Drugs.com lists upper respiratory infections, diarrhea, fever, headache, dry mouth, and muscle pain as the most commonly reported adverse effects, and some patients still experience drowsiness despite its non-sedating label Drugs.com.

Hurdles & Side Effects

• Standard OTC dosing (5 mg/day) is designed for seasonal allergies; MCAS-overlap Long COVID often requires titration up to 10-20 mg/day in divided doses, which is off-label and may need an allergist or immunologist to prescribe MCAS.